— Know what they know.
Not Investment Advice
Also trades as: LABB.MX (MEX) · $vol 2M

GNMLF OTC

Genomma Lab Internacional, S.A.B. de C.V.
1W: -1.3% 1M: -6.3% 3M: -12.8% YTD: -31.2% 1Y: -37.6% 3Y: -2.3% 5Y: -8.8%
$0.73
+0.04 (+6.51%)
 
Weekly Expected Move ±6.6%
$1 $1 $1 $1 $1
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $713.4M mcap · 671M float · 0.0012% daily turnover · Short 68% of daily vol

Cash Flow Trends

Operating Cash Flow
$77M -29.7% ▼
5Y CAGR: +3.2%
Capital Expenditures
$30M -134.0% ▼
5Y CAGR: -3.0%
Free Cash Flow
$47M -51.7% ▼
5Y CAGR: +8.9%
Dividends Paid
$43M +94.4% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
$49M -93.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$64M$71M$1.1B$2.1B$89M
Depreciation & Amort.$8M$12M$271M$360M$21M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$40M-$14M$459M-$469M-$33M
Other Non-Cash Items$6M$5M-$1.7B$1.0B-$11M
Operating Cash Flow$54M$85M$94M$3.0B$77M
— Investing Activities —
Capital Expenditures-$41M-$22M-$20M-$228M-$32M
Acquisitions (Net)$287K$1M$0$0-$7M
Investment Purchases$0-$206M-$145M-$2M$0
Investment Sales$0$0$0$0$0
Other Investing$0-$4M$138M-$503M-$9M
Investing Cash Flow-$40M-$21M-$27M-$732M-$48M
— Financing Activities —
Net Debt Issuance-$522M$25M-$89M$125M$67M
Stock Repurchased-$156M-$51M-$162M-$80M$0
Dividends Paid-$19M-$40M-$581M-$779M-$43M
Other Financing$871M-$4M$781M-$948M-$4M
Financing Cash Flow-$51M-$44M-$51M-$1.6B$17M
Net Change in Cash-$44M$16M$21M$802M$49M
Cash End of Period$62M$77M$98M$2.3B$159M
Free Cash Flow$14M$64M$74M$96M$47M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms